Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
Clinical trial NCT05322148 · COMPLETED
Trial details
- NCT number
- NCT05322148
- Sponsor
- Research Insight LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-03
- Primary completion
- 2022-11-17
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.